3 Things You Need to Know
Standard of careIsn't working
You needIndividualized treatment
TimeIs of the essence
Nick: Patient Survivor
The day after his graduation from San Diego State University, Nick was diagnosed with a recurrence of his malignant meningioma. Nick knew he wasn’t going to have a lot of options, but we had just opened a Phase 0 clinical trial for this exact indication.
Tumors We Treat
As the Ivy Brain Tumor Center grows, every patient, regardless of diagnosis or stage of the brain tumor, will have the option to enroll in a Phase 0 clinical trial.
Common subtypes include astrocytoma, oligodendroglioma, glioblastoma, and gliosarcoma
Also known as ‘secondary’ brain tumors; originate from cancer in another part of the body
Primary brain tumors derived from the lining of the brain, known as the meninges
Arises from the ependymal cells that line the ventricles of the brain and the center of the spinal cord
Arises from small nests of cells near the pituitary stalk at the base of the skull, near the pituitary gland, third ventricle, and optic nerve
Occurs in the pineal region of the brain that may or may not involve the pineal gland
COMMUNITY OF CAREGIVERS
First Patient Treated in Ivy Brain Tumor Center’s Phase 0 Clinical Trial of Pamiparib in Newly Diagnosed and Recurrent Glioblastoma
The Ivy Brain Tumor Center at Barrow Neurological Institute has announced the first patient has been treated in a Phase 0 clinical trial of pamiparib in newly diagnosed glioblastoma (nGBM) and recurrent glioblastoma (rGBM). This is the first Phase 0 clinical trial open to newly diagnosed glioblastoma patients.
It’s Personal: Dr. Robert F. Spetzler
World-renowned neurosurgeon, Dr. Robert F. Spetzler, recalls his sister-in-law’s diagnosis with glioblastoma and the personal connections that guided him through his career.
Drug Researchers Need to Learn to “Fail Fast”
In this Techonomy exclusive from Dr. Nader Sanai, director of the Ivy Brain Tumor Center, he discusses the “fail fast” adage associated with Silicon Valley and the implications this method could have on the healthcare industry specifically, in clinical trials.
Research and Medical Technology Advances Offer Hope for Patients with Aggressive Brain Cancer
BioSpace highlights the Ivy Brain Tumor Center’s new drug-device combination treatment for glioblastoma. This article depicts the collaborative effort between the Ivy Center and SonALAsense and the promising GBM therapy on the horizon.
Promising treatment for deadly Glioblastoma being tested on humans at Ivy Brain Tumor Center
A promising non-invasive treatment to effectively and safely destroy deadly brain tumors is being tested on human patients for the first time ever at the Ivy Brain Tumor Center at the Barrow Neurological Institute in Phoenix.